EQT Life Sciences led a CHF27m Series B extension in Noema Pharma.

EQT Life Sciences led a CHF27m Series B extension in Noema Pharma, a clinical-stage biotech company. With its investment in Noema Pharma, EQT Life Sciences joins the syndicate of previous Series B investors including Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus and UPMC Enterprises.